Comparison in Japan T80/A5 (Telmisartan 80 mg and Amlodipine 5 mg) and T40/A5 (Telmisartan 40 mg and Amlodipine 5 mg)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 225 participants.
Also called NCT01286558
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 225 participants
- Sponsor
- Registry
-
NCT01286558
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- Not reported
- Results first posted
- Countries
- Japan
- Registry status
- Completed
Technical summary
Registry record NCT01286558. Randomized; double masking; primary purpose treatment. Start 2011-01 (registry gives no type); primary completion 2011-09 (actual). Results posted on 2012-10-22.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparison in Japan T80/A5 (Telmisartan 80 mg and Amlodipine 5 mg) and T40/A5 (Telmisartan 40 mg and Amlodipine 5 mg)
- Condition
- Hypertension
- Intervention (Drug)
- 40 mg telmisartan
- Intervention (Drug)
- 5 mg amlodipine
- Intervention (Drug)
- 5 mg amlodipine
- Intervention (Drug)
- 80 mg telmisartan
- Lead sponsor
- Boehringer Ingelheim
Record details
- Record id
cardio:ct-nct01286558- Content hash
1ff4ffc9d3e0ae8ee663b89fa0c4f4a5d33fb8ed413f99ef2ac5acda5523d247